In bacteria-induced colon cancer, IL-17 and IL-22-producing colonic ILCs are involved in driving pro-tumor responses; specifically, IL-22 sustains inflammation during cancer by STAT3 phosphorylation in epithelial cells inducing proliferation [68]. The gene discussed is IL22; the disease is malignant colon neoplasm.